Login / Signup

Steroid-responsive encephalopathy with a peculiar CSF biomarker profile in an 89-year-old man.

Jussi O T SipiläEero RissanenJaana KorpelaMarkku Päivärinta
Published in: Oxford medical case reports (2018)
Being treatable, steroid-responsive encephalopathy associated with autoimmune thyroiditis (SREAT), or Hashimoto's encephalopathy, should be distinguished from untreatable conditions. Our patient was a previously healthy 89-year-old man, who presented with cognitive and balance deterioration over several months. His cerebrospinal fluid (CSF) examination was positive for protein 14-3-3 but no other test suggested Creutzfeldt-Jacob disease. His condition improved markedly, although not fully, with intravenous corticosteroids. In control CSF sampling, protein 14-3-3 was negative but a biomarker signature consistent with Alzheimer's disease was observed. SREAT should be considered also in the very elderly in case of subacute encephalopathy.
Keyphrases
  • cerebrospinal fluid
  • early onset
  • cancer therapy
  • protein protein
  • multiple sclerosis
  • case report
  • binding protein
  • high dose
  • drug delivery
  • low dose
  • drug induced
  • community dwelling